BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Messick TE, Tolvinski L, Zartler ER, Moberg A, Frostell Å, Smith GR, Reitz AB, Lieberman PM. Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. Molecules 2020;25:E1760. [PMID: 32290261 DOI: 10.3390/molecules25071760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Berwanger A, Empting M. KSHV-specific antivirals targeting the protein-DNA interaction of the latency-associated nuclear antigen. Future Med Chem 2021;13:1141-51. [PMID: 34036806 DOI: 10.4155/fmc-2021-0059] [Reference Citation Analysis]
2 Jakhmola S, Jonniya NA, Sk MF, Rani A, Kar P, Jha HC. Identification of Potential Inhibitors against Epstein-Barr Virus Nuclear Antigen 1 (EBNA1): An Insight from Docking and Molecular Dynamic Simulations. ACS Chem Neurosci 2021;12:3060-72. [PMID: 34340305 DOI: 10.1021/acschemneuro.1c00350] [Reference Citation Analysis]
3 de Esch IJP, Erlanson DA, Jahnke W, Johnson CN, Walsh L. Fragment-to-Lead Medicinal Chemistry Publications in 2020. J Med Chem 2021. [PMID: 34928151 DOI: 10.1021/acs.jmedchem.1c01803] [Reference Citation Analysis]
4 Calderon A, Soldan SS, De Leo A, Deng Z, Frase DM, Anderson EM, Zhang Y, Vladimirova O, Lu F, Leung JC, Murphy ME, Lieberman PM. Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism. Oncotarget 2020;11:4224-42. [PMID: 33245718 DOI: 10.18632/oncotarget.27815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Soldan SS, Anderson EM, Frase DM, Zhang Y, Caruso LB, Wang Y, Deakyne JS, Gewurz BE, Tempera I, Lieberman PM, Messick TE. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer. Gastric Cancer 2021;24:1076-88. [PMID: 33929613 DOI: 10.1007/s10120-021-01193-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]